LAUSR

There is a compelling need to evaluate the real-world health effects of medical products outside of tightly controlled pre-approval clinical trials. This is done through pharmacoepidemiology, which is the study of the health effects of medical products (including drugs, biologicals, and medical devices and diagnostics) in populations, often using non-randomized designs. Recent developments in pharmacoepidemiology span changes in the focus of research questions, research designs, data used, and statistical analysis methods. Developments in these areas are thought to improve the value of the evidence produced by such studies, and are prompting greater use of real-world evidence to inform clinical, regulatory, and reimbursement decisions.